Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer

As our understanding of the molecular pathways driving tumorigenesis improves and more druggable targets are identified, we have witnessed a concomitant increase in the development and production of novel molecularly targeted agents. Radiotherapy is commonly used in the treatment of various malignan...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2013-07, Vol.14 (7), p.14800-14832
Hauptverfasser:	Alcorn, Sara, Walker, Amanda J, Gandhi, Nishant, Narang, Amol, Wild, Aaron T, Hales, Russell K, Herman, Joseph M, Song, Danny Y, Deweese, Theodore L, Antonarakis, Emmanuel S, Tran, Phuoc T
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biomarkers - metabolism Clinical Trials as Topic Drug Evaluation, Preclinical HSP90 Heat-Shock Proteins - antagonists & inhibitors HSP90 Heat-Shock Proteins - metabolism Humans Male Prostatic Neoplasms - radiotherapy Radiation-Sensitizing Agents - therapeutic use Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - metabolism Review src-Family Kinases - antagonists & inhibitors src-Family Kinases - metabolism TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!